🇺🇸 TDF with a boosted protease inhibitor in United States

TDF with a boosted protease inhibitor (TDF with a boosted protease inhibitor) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

TDF with a boosted protease inhibitor in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is TDF with a boosted protease inhibitor approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for TDF with a boosted protease inhibitor in United States?

University of Colorado, Denver is the originator. The local marketing authorisation holder may differ — check the official source linked above.